Granules India to acquire Auctus Pharma
The acquisition is expected to be completed in the next three to six months.
Hyderabad, November 4, 2013: Granuels India announced the signing of a definite agreement for acquiring Auctus Pharma, a manufacturer of active pharmaceutical ingredients (API). While both the company did not reveal the financial details of the transaction, the acquisition process is expected to be completed in the next three to six months.
It may be noted here that Auctus has an API facility at the Pharmacity in Vishakhapatnam and an intermediate facility in Hyderabad.
The API facility has approvals from various regulatory agencies including the USFDA, Health Canada and WHO-GMP. It is expected that Granuels will leverage Auctus’ regulatory approvals and will offer valuable products to the consumers providing supply security in all stages from key intermediaries to finished dosages.